Nanoparticle Vaccine for Many SARS-Like Coronaviruses

Researchers at the California Institute of Technology, better known as Caltech, have developed a nanoparticle vaccine that appears to confer broad protection against SARS-like betacoronaviruses. This includes SARS-CoV-2, responsible for the current pandemic, and SARS-CoV, which caused the original SARS pandemic in the early 2000s.

(link is external)

How We Solved Sidekiq Memory Issue In Rails Application

The engineering team at Tata 1mg was facing an unusual behavior with the background server where we were using Sidekiq to process the jobs asynchronously. The memory on the server was reaching nearly 100% in about a few days. The pattern was observed at a gap of a cycle of 10–12 days. This needed constant monitoring and a restart of the Sidekiq process manually every time the memory exceeded 80%.We conducted research on the problem and did a root cause analysis, which yielded some specific pattern that was being repeated and causing the issue.

(link is external)

Surgical Dressing Helps Kill Melanoma, Regenerate Healthy Cells

Scientists at the University of Nottingham in the UK have created a surgical dressing that is specifically designed to facilitate and enhance photothermal therapy following melanoma resection. The dressing allows for near-infrared photothermal therapy that lasts just 15 seconds every 48 hours. The concept involves killing any remaining melanoma cells, while encouraging healthy cells to regenerate within the resection site.

(link is external)

TORdx LUNG Test for Donor Lung Assessment: Interview with Eric Brouwer, Chief Scientific Officer at SQI Diagnostics

SQI Diagnostics, a medtech company based in Canada, is developing the TORdx LUNG Test. The technology is intended to assist clinicians in assessing donor lungs in their suitability for transplantation. At present, clinicians typically assess donor lungs using qualitative variables, such as donor health and lung size. One of the most important factors, lung inflammation, is difficult to assess, and clinicians will often play it safe and reject an organ if there is any doubt about it.

(link is external)

Improving Transplant Survival with Organ Preservation Tech: Interview with Dr. Anderson, CEO of Paragonix

Paragonix Technologies, a medtech company based in Massachusetts, created the SherpaPak, an FDA organ transportation device that is intended to keep donor organs safe and viable on their journey to a transplant recipient. As the viability of a donor organ can mean life or death for the receiving patient, it makes sense to take exceptional care of it in transit.

(link is external)